Study Title

A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer (COMPPARE)

Purpose

To determine if prostate cancer patients treated with proton therapy, as compared to IMRT, experience:

Improved quality of life

Reduced toxicity

Non-inferior or even superior cancer control

To determine if Hypofractionated proton therapy is non-inferior to standard fractionated proton therapy in patient-reported outcomes & physician-reported toxicity.

Eligibility

Study Process